Psoriasis
Atopic Dermatitis
Wound Healing
Skin Grafting
Non-GLP Skin Toxicology
Stroke
Neurodegenerative Diseases (AD’s, PD’s)
Psychopharmacology
CNS-PK
Pulmonary Arterial Hypertension
Ischemia Reperfusion
Heart failures (HFpEF & HFrEF)
Gastrointestinal disorders
Metabolic disturbances
Regulatory food toxicology
About us
ETAP-Lab is an independent Contract Research Organization (CRO)
ETAP-Lab provides preclinical pharmacology and research services, as well as scientific expertise, to Pharmaceutical and Agro-Food industries. Our activity focuses on In Vivo models of pathologies and toxicology studies in rodents to support drug and nutraceutic R&D for our sponsors.
Since the foundation in 1991, ETAP-Lab’s Scientists have an in-depth expertise in pathology modeling with rodents. By respecting rodent chronobiology and natural behaviors, ETAP-Lab proposes research models with added translational value. All our models are customizable and original specific models can be set-up and validated on request.
Subscribe to our newsletter
Our News
-
World Parkinson’s Day 2024 – Towards improved screening tools for Parkinson’s disease
🌍Today is World Parkinson’s Day, dedicated to increase public awareness and understanding of this disease which affects over 10 million people worldwide, making it the second leading of neurodegenerative disease
-
Poster AD/PD International Conference | Brain-On-Chip Project
🧠 March 5-9 - Lisbon - AD/PD International Conference | Explore the research findings of ETAP-Lab and NETRI from the BIO-DIAMOND project at the poster titled :Advancing Alzheimer's Disease Models for
-
ETAP-Lab announces the acquisition of SYNCROSOME
ETAP-Lab announces the acquisition of SYNCROSOME, a CRO specialising in preclinical in vivo pharmacology services focused on cardiovascular pathologies. 🚀 This represents a significant step forward in the implementation of